| |
Tests Available
(Please note: we do not supply kits - we do assays on supplied samples.)
Larger batches and multiple test requests will be discounted: please contact us with your requirements and we will be pleased to quote.
Screening Tests:
- Prothrombin Time (PT)
- activated Partial Thromboplastin Time (aPTT)
- Thrombin Clotting Time (TCT)
- Kaolin Clotting Time (KCT)
Assessment of the Fibrinolytic Pathway:
- Alpha-2-antiplasmin - functional assay
- Euglobulin Lysis Time
- Fibrinogen/fibrin degradation products (FDP)
- Plasmin alpha-2-antiplasmin complex (PAP)
- Plasminogen Activator Inhibitor - antigen (PAI-1)
- Plasminogen Activator Inhibitor - functional (PAI-1)
- Plasminogen - antigen
- Plasminogen - functional assay
- Thrombin Activatable Fibrinolytic Inhibitor (TAFI)
- Tissue Plasminogen Activator (t-PA) - total antigen
- Tissue Plasminogen Activator (t-PA) - functional assay
Thrombosis Screening Tests:
- Activated Protein C Resistance assay (APCR)
- Anti-thrombin - antigen
- Anti-thrombin - functional assay
- Factor XI antigen
- Heparin Cofactor II - functional (chromogenic)
- Heparin Cofactor II - antigen
- Heparin-induced antibody assay (HIT):
• PF4 Binding assay
• Serotonin Release assay
- Homocysteine
- Lipoprotein (a)
- Protein C - antigen
- Protein C - functional assay (Clotting)
- Protein C - functional assay (chromogenic)
- Protein S - antigen (total and/or free antigen)
- Protein S - functional assay (Clotting)
- Reptilase
- Tissue Factor Pathway Inhibitor (TFPI)
Markers of Thrombin Generation:
- Thrombin-antithrombin Complex (TAT)
- Prothrombin fragment 1.2 (F1.2)
- Activated Factor VII (VIIa)
- D-Dimer (Quantitative and Semi-Quantitative)
- Soluble Fibrin Monomer
- Human Tissue Factor Ag
- Endogenous thrombin potential
Markers of Platelet Activation:
- Beta-Thromboglobulin (BTG)
- Platelet Factor 4 (PF4)
- P-Selectin
Measurement of thromboxane B2 suppression (Aspirin resistance)
- 11-dehydro Thromboxane B2 (Urine)
- Serum Thromboxane B2 assay.
Markers of Endothelial Activation:
- sE-Selectin
- Endothelin 1
Monitoring Anticoagulant Therapy:
- Heparin anti-IIa assay
- Heparin anti-Xa assay (LMWH, UFH, Fondaparinux)
- Hirudin assay
- Ecarin Clotting Time
- Anti-Xa Heparin Assays for establishing an aPTT therapeutic range for Unfractionated Heparin (UFH).
Antiphospholipid Antibody Evaluation:
- Anticardiolipin assay - specific measurement - IgG - IgM - IgA
- Anti-phosphotidylserine
- Anti-beta-2-glycoprotein
- Clotting assays for Lupus Anticoagulant:
- Dilute Russell viper venom time (DRVV)
- Lupus sensitive aPTT
- Dilute prothrombin time
- Kaolin Clotting time
- Confirmation Tests:
- Hexagonal phospholipid
- RVV Confirmation
Coagulation Protein Analysis:
- Coagulant Assays - Factor II to XII Functional
- Coagulant Assays - Factor II to XII Antigen
- Factor VIII (Chromogenic)
- Factor Inhibitor (FII to XII)
- Factor VIII Inhibitor assay (Bethesda)
- Factor XIII Assay - Quantitative (Chromogenic)
- Fibrinogen - Clauss functional Assay
- Fibrinogen antigen
- Prekallikrein Assay (Chromogenic)
- von Willebrand Factor antigen assay (vWF:ag)
- von Willebrand Ristocetin CoFactor
- Tissue Factor Acitivty
DNA Analysis:
- Factor V Leiden R506Q mutation
- Prothrombin 20210 AG genotype
- Methyl Tetrahydrofolate Reductase (MTHFR) Mutation
- Cytochrome P 450 CYP2C9 *2 & CYP2C9 *3
- VKORC1 (vitamin K epoxide reductase complex, subunit 1)
Miscellaneous:
- Adiponectin
- Procalcitonin
Cytokines
- IL-1 beta
- IL-1 beta High Sensitivity
- sIL-2R
- IL-6
- IL-1ra
- IFN-gamma
- MMP-3
- MMP-9
- s-ICAM-1
- s-VCAM-1
- TNF-alpha
- TNF-alpha High Sensitivity
- TGF-alpha
- TGF-beta
- TNF sTNF R1
- TNF sTNF R2
Animal Studies:
- Rabbit: Fibrinogen Antigen Assay, FDP Antigen Assay
- Rabbit & Pig: Thrombin-Antithrombin (TAT)
- Pig: D-Dimer, Tissue Plasminogen Activator Antigen (t-PA), IL-6, CRP, TNF-α
- Canine: Factor Assays, Antithrombin, vWF antigen
- Anti-Xa & Anti-IIa assay for all animals
Note that most functional assays can be applied to animal studies. |
|
 |
NOW AVAILABLE!!
Microparticle Activity Analysis
For more information see our News and Upcoming Events page.
Genotyping for Warfarin Therapy Cytochrome
P450 2C9 gene (CYP2C9) & Vitamin K Epoxide Reductase Complex 1 gene (VKORC1) genotyping is now available. For more information see our News and Upcoming Events page.
XXII Congress of the International
Society on Thrombosis and
Haemostasis
The XXII ISTH Congress is to be held in Boston from July 11 to 16, 2009. Marilyn Johnston has had two abstracts accepted for poster presentation and publication. For more information see our News and Upcoming Events page.
Molecular Cancer Therapeutics
Article
HRL is pleased to inform of a publication by
Lucy Shin, the recipient of the HRL Scholarship for 2006, titled "Effects of the chemotherapeutic agent doxorubicon on the protein C anticoagulant pathway". For more information see our News and Upcoming Events page.
PROCALCITONIN
Testing
The B·R·A·H·M·S PCT LIA assay has been cleared by the FDA for the early diagnosis of patients at risk for progression to severe sepsis.
HRL offers Procalcitonin (PCT) testing for research purposes. The clinical utility in select patient populations has already been identified and continued studies to discover the optimal utilization of this marker as it relates to patient management is foreseen. The availability of this FDA-cleared PCT
assay will encourage further international
clinical-scientific studies. Click here to view the News and Upcoming Events page. |
|
|